The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Melekhov A.V.

Pirogov Russian National Research Medical University, Moscow

Gendlin G.E.

GBOU VPO "Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova", Moskva

Alekseeva E.M.

Pirogov Russian National Research Medical University, Moscow, Russia

Dadashova E.F.

Pirogov Russian National Research Medical University, Moscow, Russia

Nikitin I.G.

Pirogov Russian National Research Medical University, Moscow, Russia

Anisimova A.V.

GBOU VPO "Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova", Moskva

The frequency of cerebrovascular disorders in patients with different forms of atrial fibrillation

Authors:

Melekhov A.V., Gendlin G.E., Alekseeva E.M., Dadashova E.F., Nikitin I.G., Anisimova A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3‑2): 3‑10

DOI: 10.17116/jnevro2017117323-10

Views: 1299

Downloaded: 45

Download PDF (RU)
Contact the author
Table of contents

THE FREQUENCY OF CEREBROVASCULAR DISORDERS IN PATIENTS WITH DIFFERENT FORMS OF ATRIAL FIBRILLATION
THE FREQUENCY OF CEREBROVASCULAR DISORDERS IN PATIENTS WITH DIFFERENT FORMS OF ATRIAL FIBRILLATION

To cite this article:

Melekhov AV, Gendlin GE, Alekseeva EM, Dadashova EF, Nikitin IG, Anisimova AV. The frequency of cerebrovascular disorders in patients with different forms of atrial fibrillation. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3‑2):3‑10. (In Russ.)
https://doi.org/10.17116/jnevro2017117323-10

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
 
МСФ на ЯМ
Close metadata
Recommended articles:
Effi­cacy and Safety of Different Anti­coagulation Regi­mens for Deep Vein Thro­mbosis in Real Clinical Practice. Journal of Venous Diso­rders. 2024;(2):89-99
The impact of arti­ficial inte­lligence on double reading of mammograms. Russian Journal of Preventive Medi­cine. 2024;(5):32-37
The role of gene poly­morphism in hemo­static diso­rders in children unde­rgoing cardiac surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(3):43-48
Reco­nstructive plastic surgery in combined treatment of breast cancer: predictive risk factors of complications and reco­nstruction failure. P.A. Herzen Journal of Onco­logy. 2024;(3):13-19
Effi­cacy and Safety of Different Anti­coagulation Regi­mens for Deep Vein Thro­mbosis in Real Clinical Practice. Journal of Venous Diso­rders. 2024;(2):89-99
Asso­ciations of smoking status with the composition of fatty acids in blood plasma in men in Novo­sibirsk («ESSE-RF3» in the Novo­sibirsk region). Russian Journal of Preventive Medi­cine. 2024;(6):36-41
Risk factors for the iron defi­ciency anemia deve­lopment in infa­nts: pylot study. Russian Journal of Preventive Medi­cine. 2024;(6):53-59
Methods of cost-effectiveness evaluation of endo­vascular patent fora­men ovale closure for seco­ndary prevention of cryptogenic stroke. Russian Journal of Preventive Medi­cine. 2024;(6):105-110
Primary prevention of colo­rectal cancer and technologies for its implementation into practical health care. Russian Journal of Preventive Medi­cine. 2024;(6):111-117
The overview of the researches of unhealthy foods and beve­rages marketing on TV. Russian Journal of Preventive Medi­cine. 2024;(6):118-122

Objective. To study the frequency of blood circulation disorders (BCD) in patients with different forms of atrial fibrillation (AF) and its relationship with AF duration and treatment with anticoagulants. Material and methods. Medical records and medical history of 1626 patients with non-valvural AF were analyzed in Moscow from 2009 to 2015. Results. Patients with persistent AF were older and had a higher risk of thromboembolic and hemorrhagic complications. In the group of patients with paroxysmal and persistent AF, percentage of patients with BCD (including recurrent ones) was decreased by 13.1 and 28.9% compared to the patients with persistent form. There was no correlation between AF duration and BCD frequency. The frequency of using anticoagulants was 10.8% in outpatients and 42.8% in inpatients. Patients with persistent AF received anticoagulants less frequently than patients with less persistent forms. Conclusion. Persistent AF is associated with the higher risk of BCD. The prevention of BCD in patients with persistent AF was insufficient compared to that in patients with less persistent forms.

Keywords:

paroxysmal atrial fibrillation
persistent atrial fibrillation
stroke
risk factors
prevention
anticoagulants

Authors:

Melekhov A.V.

Pirogov Russian National Research Medical University, Moscow

Gendlin G.E.

GBOU VPO "Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova", Moskva

Alekseeva E.M.

Pirogov Russian National Research Medical University, Moscow, Russia

Dadashova E.F.

Pirogov Russian National Research Medical University, Moscow, Russia

Nikitin I.G.

Pirogov Russian National Research Medical University, Moscow, Russia

Anisimova A.V.

GBOU VPO "Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova", Moskva

List of references:

  1. Sulmov VA. Diagnosis and treatment of atrial fibrillation. Recommendations RSC, RSSA AND ACS, 2012. Rossijskiy cardiologicheskiy jurnal. 2013;4(102):3:4-51. (In Russ.).
  2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; Authors/Task Force Members.; Document Reviewers: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016. doi:10.1093/eurheartj/ehw210
  3. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics — 2016 Update: a report from the American Heart Association. Circulation. 2016;133:38-360. doi:10.1161/CIR.0000000000000350
  4. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754-3832. doi:10.1161/STR.0000000000000046
  5. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6:150-161. doi:10.2174/157340310791658730
  6. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S. ACTIVE W Investigators. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol. 2007;50:2156-2161. doi:10.1016/j.jacc.2007.07.076
  7. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 2000;35:183-187. doi:10.1016/S0735-1097(99)00489-1
  8. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31:967-975. doi:10.1093/eurheartj/ehn599
  9. Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, et al. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Int J Cardiol.2013;167:2682—2687. doi:10.1016/j.ijcard.2012.06.118
  10. Disertori M, Franzosi MG, Barlera S, Cosmi F, Quintarelli S, Favero C, et al; GISSI-AF Investigators. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial. BMC Cardiovasc Disord. 2013;13:28. doi:10.1186/1471-2261-13-28
  11. Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, et al; Euro Heart Survey Investigators. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J. 2008;29:915-922. doi:10.1093/eurheartj/ehn101
  12. Hsu JC, Chan PS, Tang F, Maddox TM, Marcus GM. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation. Am J Med. 2015;128(6):654.1-654.10. doi:10.1016/j.amjmed.2014.11.035
  13. Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ. ROCKET-AF Steering Committee and Investigators. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J. 2015;36:288-296. doi:10.1093/eurheartj/ehu359
  14. Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013;34:2464-2471. doi:10.1093/eurheartj/eht135
  15. Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M.Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2015;36:281-287. doi:10.1093/eurheartj/ehu307
  16. Takabayashi K, Hamatani Y, Yamashita Y, Takagi D, Unoki T, Ishii M. Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry. Stroke. 2015;46:3354-3361. doi:10.1161/STROKEAHA.115.010947
  17. Senoo K, Lip GY, Lane DA, Buller HR, Kotecha D. Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS Trial. Stroke. 2015;46:2523-2528. doi:10.1161/STROKEAHA.115.009487
  18. Inoue H, Atarashi H, Okumura K, Yamashita T, Kumagai N, Origasa H. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry. Circ J. 2014;78:2388-2393. doi:10.1253/circj.CJ-14-0507
  19. Takabayashi K, Hamatani Y, Yamashita Y, Takagi D, Unoki T, Ishii M, Iguchi M, Masunaga N, Ogawa H, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GY, Akao M. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry. Stroke. 2015;46(12):3354-3361. doi:10.1161/STROKEAHA.115.010947
  20. Koga M, Yoshimura S, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Todo K, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Yagita Y, Kario K, Shiozawa M, Sato S, Yamagami H, Arihiro S, Toyoda K; SAMURAI Study Investigators. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation. Stroke. 2016;47(10):2582-2588. doi:10.1161/STROKEAHA.116.013746
  21. Naess H, Waje-Andreassen U, Thomassen L. Persistent atrial fibrillation is associated with worse prognosis than paroxysmal atrial fibrillation in acute cerebral infarction. ISRN Cardiol. 2012;650915. doi:10.5402/2012/650915
  22. Deguchi I, Fukuoka T, Hayashi T, Maruyama H, Sehara Y, Kato Y. Clinical outcomes of persistent and paroxysmal atrial fibrillation in patients with stroke. J Stroke Cerebrovasc Dis. 2014;23:2840-2844. doi:10.1016/j.jstrokecerebrovasdis.2014.07.010
  23. Deguchi I, Hayashi T, Fukuoka T, Kobayashi S, Tanahashi N. Japan Standard Stroke Registry Study Group. Features of cardioembolic stroke with persistent and paroxysmal atrial fibrillation — a study with the Japan Stroke Registry. Eur J Neurol. 2015;22:1215-1219. doi:10.1111/ene.12728
  24. Deguchi I, Fukuoka T, Hayashi T, Maruyama H, Sehara Y, Kato Y, Horiuchi Y, Nagamine Y, Sano H, Tanahashi N. Clinical outcomes of persistent and paroxysmal atrial fibrillation in patients with stroke. J Stroke Cerebrovasc Dis. 2014;23(10):2840-2844. doi:10.1016/j.jstrokecerebrovasdis.2014.07.010
  25. Gaita F, Corsinovi L, Anselmino M, Raimondo C, Pianelli M, Toso E, Bergamasco L, Boffano C, Valentini MC, Cesarani F, Scaglione M. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol. 2013;62(21):1990-1997. doi:10.1016/j.jacc.2013.05.074
  26. Gendlin GE, Melekhov AV, Alekseeva EM, Storozhakov GI. Nonvalvular atrial fibrillation and recurrent ischemic strokes. Vrach. 2015;10:28-31. (In Russ.).
  27. Melekhov AV, Gendlin GE, Alekseeva EM, Dadashova EF, Storozhakov GI, Sertakova OV, Zaharova II. The cardiologic prevention of stroke: current state of problem. Rossijskiy Medicinskiy Jurnal. 2015;5:12-17. (In Russ.).
  28. Melekhov AV, Gendlin GE, Nkitin IG, Alekseeva EM, Dadashova EF, Zaharova II, Varentsov SI. Treatment of patients with atrial fibrillation: reallife practice in Moscow registry at 2009—2015. Jurnal Serdce. 2016;6:15-21. (In Russ.).
  29. Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lip GY. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. Europace. 2016;18(5):648-657. doi:10.1093/europace/euv390
  30. Yoshida K, Obokata M, Kurosawa K, Sorimachi H, Kurabayashi M, Negishi K. Effect of Sex Differences on the Association Between Stroke Risk and Left Atrial Anatomy or Mechanics in Patients With Atrial Fibrillation. Circ Cardiovasc Imaging. 2016;9(10):34-39. doi:10.1161/CIRCIMAGING.116.004999
  31. Bossard M, Kreuzmann R, Hochgruber T, Krisai P, Zimmermann AJ, Aeschbacher S, Pumpol K, Kessel-Schaefer A, Stephan FP, Handschin N, Sticherling C, Osswald S, Kaufmann BA, Paré G, Kühne M, Conen D. Determinants of Left Atrial Volume in Patients with Atrial Fibrillation. PLoS One. 2016;11(10):0164145. doi:10.1371/journal.pone.0164145

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.